153 related articles for article (PubMed ID: 23076400)
1. Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review).
Song K; Wu J; Jiang C
Oncol Rep; 2013 Jan; 29(1):3-12. PubMed ID: 23076400
[TBL] [Abstract][Full Text] [Related]
2. The power and the promise of liver cancer stem cell markers.
Liu LL; Fu D; Ma Y; Shen XZ
Stem Cells Dev; 2011 Dec; 20(12):2023-30. PubMed ID: 21651381
[TBL] [Abstract][Full Text] [Related]
3. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
[TBL] [Abstract][Full Text] [Related]
4. Research progress and prospects of markers for liver cancer stem cells.
Zhu CP; Wang AQ; Zhang HH; Wan XS; Yang XB; Chen SG; Zhao HT
World J Gastroenterol; 2015 Nov; 21(42):12190-6. PubMed ID: 26576103
[TBL] [Abstract][Full Text] [Related]
5. iNOS promotes CD24
Wang R; Li Y; Tsung A; Huang H; Du Q; Yang M; Deng M; Xiong S; Wang X; Zhang L; Geller DA; Cheng B; Billiar TR
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10127-E10136. PubMed ID: 30297396
[TBL] [Abstract][Full Text] [Related]
6. Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma.
Lee TK; Cheung VC; Ng IO
Cancer Lett; 2013 Sep; 338(1):101-9. PubMed ID: 22579789
[TBL] [Abstract][Full Text] [Related]
7. Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies.
Liu YC; Yeh CT; Lin KH
Cells; 2020 May; 9(6):. PubMed ID: 32466488
[TBL] [Abstract][Full Text] [Related]
8. Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression.
Deng Y; Li M; Zhuo M; Guo P; Chen Q; Mo P; Li W; Yu C
J Biol Chem; 2021; 296():100121. PubMed ID: 33434575
[TBL] [Abstract][Full Text] [Related]
9. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling.
Ren KQ; Cao XZ; Liu ZH; Guo H; Quan MF; Liu F; Jiang L; Xiang HL; Deng XY; Cao JG
Int J Oncol; 2013 Nov; 43(5):1719-29. PubMed ID: 23970349
[TBL] [Abstract][Full Text] [Related]
10. Liver cancer stem cells: implications for a new therapeutic target.
Lee TK; Castilho A; Ma S; Ng IO
Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
[TBL] [Abstract][Full Text] [Related]
11. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
Yang XR; Xu Y; Yu B; Zhou J; Qiu SJ; Shi GM; Zhang BH; Wu WZ; Shi YH; Wu B; Yang GH; Ji Y; Fan J
Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200
[TBL] [Abstract][Full Text] [Related]
12. BMP9-ID1 signaling promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma.
Chen H; Nio K; Yamashita T; Okada H; Li R; Suda T; Li Y; Doan PTB; Seki A; Nakagawa H; Toyama T; Terashima T; Iida N; Shimakami T; Takatori H; Kawaguchi K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
Mol Oncol; 2021 Aug; 15(8):2203-2218. PubMed ID: 33834612
[TBL] [Abstract][Full Text] [Related]
13. Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma.
Zhou L; He L; Liu CH; Qiu H; Zheng L; Sample KM; Wu Q; Li J; Xie K; Ampuero J; Li Z; Lv D; Liu M; Romero-Gómez M; Hu Y; Tang H
J Exp Clin Cancer Res; 2023 Nov; 42(1):311. PubMed ID: 37993901
[TBL] [Abstract][Full Text] [Related]
14. Cellular and Molecular Biology of Cancer Stem Cells of Hepatocellular Carcinoma.
Jeng KS; Chang CF; Sheen IS; Jeng CJ; Wang CH
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674932
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma.
Pang RW; Poon RT
Curr Cancer Drug Targets; 2012 Nov; 12(9):1081-94. PubMed ID: 22873219
[TBL] [Abstract][Full Text] [Related]
16. Differential proteomic analysis of cancer stem cell properties in hepatocellular carcinomas by isobaric tag labeling and mass spectrometry.
Ko CH; Cheng CF; Lai CP; Tzu TH; Chiu CW; Lin MW; Wu SY; Sun CY; Tseng HW; Wang CC; Kuo ZK; Wang LM; Chen SF
J Proteome Res; 2013 Aug; 12(8):3573-85. PubMed ID: 23782096
[TBL] [Abstract][Full Text] [Related]
17. Biology of hepatic cancer stem cells.
Tong CM; Ma S; Guan XY
J Gastroenterol Hepatol; 2011 Aug; 26(8):1229-37. PubMed ID: 21557770
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.
Chiba T; Kamiya A; Yokosuka O; Iwama A
Cancer Lett; 2009 Dec; 286(2):145-53. PubMed ID: 19464789
[TBL] [Abstract][Full Text] [Related]
19. Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133.
Hur W; Ryu JY; Kim HU; Hong SW; Lee EB; Lee SY; Yoon SK
Sci Rep; 2017 Apr; 7():45557. PubMed ID: 28367990
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells and hepatocellular carcinoma.
Yao Z; Mishra L
Cancer Biol Ther; 2009 Sep; 8(18):1691-8. PubMed ID: 19901516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
